{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T02:50:11Z","timestamp":1768013411162,"version":"3.49.0"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"20","license":[{"start":{"date-parts":[[2021,3,22]],"date-time":"2021-03-22T00:00:00Z","timestamp":1616371200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["U01HL130163"],"award-info":[{"award-number":["U01HL130163"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["U01HL130204"],"award-info":[{"award-number":["U01HL130204"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014588","name":"Sanofi Pasteur","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014588","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["T32HL007604"],"award-info":[{"award-number":["T32HL007604"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,5,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The link between viral respiratory infection and non-pulmonary organ-specific injury, including cardiac injury, has become increasingly appreciated during the current coronavirus disease 2019 (COVID-19) pandemic. Even prior to the pandemic, however, the association between acute infection with influenza and elevated cardiovascular risk was evident. The recently published results of the NHLBI-funded INfluenza Vaccine to Effectively Stop CardioThoracic Events and Decompensated (INVESTED) trial, a 5200 patient comparative effectiveness study of high-dose vs. standard-dose influenza vaccine to reduce cardiopulmonary events and mortality in a high-risk cardiovascular population, found no difference between strategies. However, the broader implications of influenza vaccine as a strategy to reduce morbidity in high-risk patients remain extremely important, with randomized controlled trial and observational data supporting vaccination in high-risk patients with cardiovascular disease. Given a favourable risk-benefit profile and widespread availability at generally low cost, we contend that influenza vaccination should remain a centrepiece of cardiovascular risk mitigation and describe the broader context of underutilization of this strategy. Few therapeutics in medicine offer seasonal efficacy from a single administration with generally mild, transient side effects, and exceedingly low rates of serious adverse effects. Infection control measures such as physical distancing, hand washing, and the use of masks during the COVID-19 pandemic have already been associated with substantially curtailed incidence of influenza outbreaks across the globe. Appending annual influenza vaccination to these measures represents an important public health and moral imperative.<\/jats:p>","DOI":"10.1093\/eurheartj\/ehab133","type":"journal-article","created":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T20:13:08Z","timestamp":1614197588000},"page":"2015-2018","source":"Crossref","is-referenced-by-count":7,"title":["Influenza vaccination: a \u2018shot\u2019 at INVESTing in cardiovascular health"],"prefix":"10.1093","volume":"42","author":[{"given":"Ankeet S","family":"Bhatt","sequence":"first","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School , 75 Francis Sreet, Boston, MA 02115, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orly","family":"Vardeny","sequence":"additional","affiliation":[{"name":"Center for Care Delivery and Outcomes Research, Minneapolis VA Health Care System, University of Minnesota , MN, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7402-9584","authenticated-orcid":false,"given":"Jacob A","family":"Udell","sequence":"additional","affiliation":[{"name":"Peter Munk Cardiac Centre, Toronto General Hospital , Toronto, ON, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"Joseph","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School , 75 Francis Sreet, Boston, MA 02115, USA"},{"name":"Department of Medicine , Boston VA, Boston, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KyungMann","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Medical Informatics, University of Wisconsin , Madison, WI, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott D","family":"Solomon","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School , 75 Francis Sreet, Boston, MA 02115, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,3,22]]},"reference":[{"key":"2022102603085943200_ehab133-B1","doi-asserted-by":"crossref","first-page":"e0118369","DOI":"10.1371\/journal.pone.0118369","article-title":"Estimating influenza disease burden from population-based surveillance data in the United States","volume":"10","author":"Reed","year":"2015","journal-title":"PLoS One"},{"key":"2022102603085943200_ehab133-B2","first-page":"334","article-title":"Influenza vaccination: a one-shot deal to reduce cardiovascular events","volume":"38","author":"Vardeny","year":"2017","journal-title":"Eur Heart J"},{"key":"2022102603085943200_ehab133-B3","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ehj.2003.10.018","article-title":"Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) Study","volume":"25","author":"Gurfinkel","year":"2004","journal-title":"Eur Heart J"},{"key":"2022102603085943200_ehab133-B4","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/jama.2013.279206","article-title":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis","volume":"310","author":"Udell","year":"2013","journal-title":"JAMA"},{"key":"2022102603085943200_ehab133-B5","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1161\/CIRCULATIONAHA.118.036788","article-title":"Influenza vaccine in heart failure","volume":"139","author":"Modin","year":"2019","journal-title":"Circulation"},{"key":"2022102603085943200_ehab133-B6","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1136\/heartjnl-2016-309983","article-title":"Influenza vaccine as a coronary intervention for prevention of myocardial infarction","volume":"102","author":"MacIntyre","year":"2016","journal-title":"Heart"},{"key":"2022102603085943200_ehab133-B7","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/eurjhf\/hfs207","article-title":"Double dose vs. standard dose influenza vaccination in patients with heart failure: a pilot study","volume":"15","author":"Van Ermen","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"2022102603085943200_ehab133-B8","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/jama.2020.23649","article-title":"Effect of high-dose trivalent vs standard-dose quadrivalent influenza vaccine on mortality or cardiopulmonary hospitalization in patients with high-risk cardiovascular disease: a randomized clinical trial","volume":"325","author":"Vardeny","year":"2021","journal-title":"JAMA"},{"key":"2022102603085943200_ehab133-B9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6908a1","article-title":"Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices\u2014United States, 2020-21 influenza season","volume":"69","author":"Grohskopf","year":"2020","journal-title":"MMWR Recomm Rep"},{"key":"2022102603085943200_ehab133-B10","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1161\/CIRCULATIONAHA.120.049118","article-title":"Cardiovascular hospitalizations, influenza activity and COVID-19 measures","volume":"142","author":"Myhre","year":"2020","journal-title":"Circulation"},{"key":"2022102603085943200_ehab133-B11","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","article-title":"2016 European Guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)","volume":"37","author":"Piepoli","year":"2016","journal-title":"Eur Heart J"},{"key":"2022102603085943200_ehab133-B12","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cardfail.2010.04.004","article-title":"HFSA 2010 comprehensive heart failure practice guideline","volume":"16","author":"Lindenfeld","year":"2010","journal-title":"J Card Fail"},{"key":"2022102603085943200_ehab133-B13","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jchf.2018.04.012","article-title":"Vaccination trends in patients with heart failure: insights from get with the guidelines-heart failure","volume":"6","author":"Bhatt","year":"2018","journal-title":"JACC Heart Fail"},{"key":"2022102603085943200_ehab133-B14","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jchf.2015.10.012","article-title":"Influenza vaccination in patients with chronic heart failure: the PARADIGM-HF trial","volume":"4","author":"Vardeny","year":"2016","journal-title":"JACC Heart Fail"},{"key":"2022102603085943200_ehab133-B15","first-page":"11","article-title":"Disparities in influenza vaccination-opportunity to extend cardiovascular prevention to millions of hearts","volume":"6","author":"Sperling","year":"2021","journal-title":"JAMA Cardiol"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/42\/20\/2015\/46624835\/ehab133.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/42\/20\/2015\/46624835\/ehab133.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T03:09:52Z","timestamp":1666753792000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/42\/20\/2015\/6179534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,22]]},"references-count":15,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2021,3,22]]},"published-print":{"date-parts":[[2021,5,21]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehab133","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,5,21]]},"published":{"date-parts":[[2021,3,22]]}}}